Meta-analysis: Accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease

Annals of Internal Medicine

Volumn 153, Issue 5, 2010, Pages 325-334

  Menke, Jan ^a,b   Larsen, Jörg ^a  

^a Sleep Laboratory   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHELATE; CONTRAST MEDIUM;

CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HUMAN; LIMB ISCHEMIA; LIMB PAIN; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOM; LEG; META ANALYSIS; METHODOLOGY; PERIPHERAL VASCULAR DISEASE; STANDARD; VASCULARIZATION;

ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; HUMANS; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL VASCULAR DISEASES; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 77956702046     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-5-201009070-00007     Document Type: Review

References (95)

1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al; American Association for Vascular Surgery. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans- Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-654. [PMID: 16549646]
2. Menke J, Lüthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2010;105:502-10. [PMID: 20152245]
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67. [PMID: 17223489]
4. Hirose K, Chikamori T, Hida S, Tanaka H, Igarashi Y, Watanabe Y, et al. Prevalence of coronary heart disease in patients with aortic aneurysm and/or peripheral artery disease. Am J Cardiol. 2009;103:1215-20. [PMID: 19406262]
5. Aronow WS, Ahmed MI, Ekundayo OJ, Allman RM, Ahmed A. A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults. Am J Cardiol. 2009;103:130-5. [PMID: 19101243]
6. Wilson JF, Laine C, Goldmann D. In the clinic. Peripheral arterial disease. Ann Intern Med. 2007;146:ITC3-1-ITC3-16. [PMID: 17339616]
7. Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc. 2007;55:583-9. [PMID: 17397438]
8. White C. Clinical practice. Intermittent claudication. N Engl J Med. 2007;356:1241-50. [PMID: 17377162]
9. Kock MC, Dijkshoorn ML, Pattynama PM, Myriam Hunink MG. Multidetector row computed tomography angiography of peripheral arterial disease. Eur Radiol. 2007;17:3208-22. [PMID: 17882427]
10. Kramer CM, Budoff MJ, Fayad ZA, Ferrari VA, Goldman C, Lesser JR, et al; American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training: developed in collaboration with the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology. Circulation. 2007;116:1318-35. [PMID: 17766696]
11. Sun Y, Parker DL. Performance analysis of maximum intensity projection algorithm for display of MRA images. IEEE Trans Med Imaging. 1999;18:1154-69. [PMID: 10695528]
12. Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA. 2009;301:415-24. [PMID: 19176443]
13. Collins R, Burch J, Cranny G, Aguiar-Ibáñez R, Craig D, Wright K, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ. 2007;334:1257. [PMID: 17548364]
14. Sun Z. Diagnostic accuracy of multislice CT angiography in peripheral arterial disease. J Vasc Interv Radiol. 2006;17:1915-21. [PMID: 17185686]
15. Heijenbrok-Kal MH, Kock MC, Hunink MG. Lower extremity arterial disease: multidetector CT angiography meta-analysis. Radiology. 2007;245:433-9. [PMID: 17848679]
16. Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology. 2000;217:105-14. [PMID: 11012430]
17. Visser K, Hunink MG. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US - a meta-analysis. Radiology. 2000;216:67-77. [PMID: 10887229]
18. Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA. 2001;285:1338-45. [PMID: 11255390]
19. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9, W64. [PMID: 19622511]
20. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. [PMID: 19622552]
21. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25. [PMID: 14606960]
22. Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. Cambridge, United Kingdom: Blackwell Scientific; 1994:443-7.
23. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882-93. [PMID: 16085191]
24. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31. [PMID: 16836745]
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. [PMID: 12958120]
26. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM; Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008;149:889-97. [PMID: 19075208]
27. Menke J. Bivariate random-effects meta-analysis of sensitivity and specificity with SAS PROC GLIMMIX. Methods Inf Med. 2010;49:54-62, 62-4. [PMID: 19936437]
28. Jones A, Huddleston E. SAS/STAT 9.2 User's Guide. 2nd ed. Cary, North Carolina: SAS Institute; 2009.
29. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329:168-9. [PMID: 15258077]
30. Biggerstaff BJ. Comparing diagnostic tests: a simple graphic using likelihood ratios. Stat Med. 2000;19:649-63. [PMID: 10700737]
31. Zwinderman AH, Bossuyt PM. We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med. 2008;27:687-97. [PMID: 17611957]
32. Maceneaney PM, Malone DE. The meaning of diagnostic test results: a spreadsheet for swift data analysis. Clin Radiol. 2000;55:227-35. [PMID: 10708618]
33. Schuetz GM, Zacharopoulou NM, Schlattmann P, Dewey M. Metaanalysis: noninvasive coronary angiography using computed tomography versus magnetic resonance imaging. Ann Intern Med. 2010;152:167-77. [PMID: 20124233]
34. Menke J. Diagnostic accuracy of contrast-enhanced MR angiography in severe carotid stenosis: meta-analysis with metaregression of different techniques. Eur Radiol. 2009;19:2204-16. [PMID: 19399505]
35. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559-73. [PMID: 12111920]
36. Bipat S, Zwinderman AH, Bossuyt PM, Stoker J. Multivariate random-effects approach: for meta-analysis of cancer staging studies. Acad Radiol. 2007;14:974-84. [PMID: 17659244]
37. Yamashita Y, Mitsuzaki K, Ogata I, Takahashi M, Hiai Y. Three-dimensional high-resolution dynamic contrast-enhanced MR angiography of the pelvis and lower extremities with use of a phased array coil and subtraction: diagnostic accuracy. J Magn Reson Imaging. 1998;8:1066-72. [PMID: 9786143]
38. Perrier E, Dubayle P, Boyer B, Mousseaux E, Larroque P, Vergos M, et al. [Comparison of magnetic resonance angiography with injection of gadolinium and conventional arteriography of the ilio-femoral arteries]. J Radiol. 1998;79:1493-8. [PMID: 9921452]
39. Ho KY, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM. Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography. Radiology. 1998;206:673-81. [PMID: 9494485]
40. Ho KY, Leiner T, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM. Peripheral vascular tree stenoses: evaluation with moving-bed infusiontracking MR angiography. Radiology. 1998;206:683-92. [PMID: 9494486]
41. Winterer JT, Laubenberger J, Scheffler K, Neumann K, Bayraktarli YR, Allmann KH, et al. Contrast-enhanced subtraction MR angiography in occlusive disease of the pelvic and lower limb arteries: results of a prospective intraindividual comparative study with digital subtraction angiography in 76 patients. J Comput Assist Tomogr. 1999;23:583-9. [PMID: 10433291]
42. Sueyoshi E, Sakamoto I, Matsuoka Y, Ogawa Y, Hayashi H, Hashmi R, et al. Aortoiliac and lower extremity arteries: comparison of three-dimensional dynamic contrast-enhanced subtraction MR angiography and conventional angiography. Radiology. 1999;210:683-8. [PMID: 10207467]
43. Meaney JF, Ridgway JP, Chakraverty S, Robertson I, Kessel D, Radjenovic A, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology. 1999;211:59-67. [PMID: 10189454]
44. Lenhart M, Djavidani B, VölkM, Strotzer M, Manke C, Requardt M, et al. [Contrast medium-enhanced MR angiography of the pelvic and leg vessels with an automated table-feed technique]. Rofo. 1999;171:442-9. [PMID: 10668508]
45. Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF. Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. AJR Am J Roentgenol. 2000;174:1127-35. [PMID: 10749264]
46. Huber A, Heuck A, Baur A, Helmberger T, Waggershauser T, Billing A, et al. Dynamic contrast-enhanced MR angiography from the distal aorta to the ankle joint with a step-by-step technique. AJR Am J Roentgenol. 2000;175:1291-8. [PMID: 11044026]
47. Lundin P, Svensson A, Henriksen E, Jonason T, Forssell C, Bäckbro B, et al. Imaging of aortoiliac arterial disease. Duplex ultrasound and MR angiography versus digital subtraction angiography. Acta Radiol. 2000;41:125-32. [PMID: 10741783]
48. Lenhart M, Herold T, VölkM, Seitz J, Manke C, Zorger N, et al. [Contrast media-enhanced MR angiography of the lower extremity arteries using a dedicated peripheral vascular coil system. First clinical results]. Rofo. 2000;172:992-9. [PMID: 11199443]
49. Carriero A, Maggialetti A, Pinto D, Salcuni M, Mansour M, Petronelli S, et al. Contrast-enhanced magnetic resonance angiography MoBI-trak in the study of peripheral vascular disease. Cardiovasc Intervent Radiol. 2002;25:42-7. [PMID: 11907773]
50. Huber A, Scheidler J, Wintersperger B, Baur A, Schmidt M, Requardt M, et al. Moving-table MR angiography of the peripheral runoff vessels: comparison of body coil and dedicated phased array coil systems. AJR Am J Roentgenol. 2003;180:1365-73. [PMID: 12704053]
51. Cronberg CN, Sjöberg S, Albrechtsson U, Leander P, Lindh M, Norgren L, et al. Peripheral arterial disease. Contrast-enhanced 3D MR angiography of the lower leg and foot compared with conventional angiography. Acta Radiol. 2003;44:59-66. [PMID: 12631001]
52. Steffens JC, Schäfer FK, Oberscheid B, Link J, Jahnke T, Heller M, et al. Bolus-chasing contrast-enhanced 3D MRA of the lower extremity. Comparison with intraarterial DSA. Acta Radiol. 2003;44:185-92. [PMID: 12694106]
53. Willmann JK, Wildermuth S, Pfammatter T, Roos JE, Seifert B, Hilfiker PR, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology. 2003;226:798-811. [PMID: 12601190]
54. Wyttenbach R, Gianella S, Alerci M, Braghetti A, Cozzi L, Gallino A. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography. Radiology. 2003;227:261-9. [PMID: 12616007]
55. Schäfer FK, Schäfer PJ, Jahnke T, Walluscheck K, Priebe M, Hentsch A, et al. [First clinical results in a study of contrast enhanced magnetic resonance angiography with the 1.0 molar gadobutrol in peripheral arterial occlusive disease - comparison to intraarterial DSA]. Rofo. 2003;175:556-64. [PMID: 12677513]
56. Krause UJ, Pabst T, Kenn W, Wittenberg G, Hahn D. Time-resolved contrast-enhanced magnetic resonance angiography of the lower extremity. Angiology. 2004;55:119-25. [PMID: 15026865]
57. Bezooijen R, van den Bosch HC, Tielbeek AV, Thelissen GR, Visser K, Hunink MG, et al. Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiography. Radiology. 2004;231:263-71. [PMID: 15068952]
58. Lapeyre M, Kobeiter H, Desgranges P, Rahmouni A, Becquemin JP, Luciani A. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol. 2005;185:1641-50. [PMID: 16304027]
59. de Vries M, de Koning PJ, de Haan MW, Kessels AG, Nelemans PJ, Nijenhuis RJ, et al. Accuracy of semiautomated analysis of 3D contrast-enhanced magnetic resonance angiography for detection and quantification of aortoiliac stenoses. Invest Radiol. 2005;40:495-503. [PMID: 16024987]
60. de Vries M, Nijenhuis RJ, Hoogeveen RM, de Haan MW, van Engelshoven JM, Leiner T. Contrast-enhanced peripheral MR angiography using SENSE in multiple stations: feasibility study. J Magn Reson Imaging. 2005;21:37-45. [PMID: 15611941]
61. Janka R, Fellner C, Wenkel E, Lang W, Bautz W, Fellner FA. Contrast-enhanced MR angiography of peripheral arteries including pedal vessels at 1.0 T: feasibility study with dedicated peripheral angiography coil. Radiology. 2005;235:319-26. [PMID: 15731370]
62. Gjønnaess E, Morken B, Sandbaek G, Stranden E, Slagsvold CE, Jørgensen JJ, et al. Gadolinium-enhanced magnetic resonance angiography, colour duplex and digital subtraction angiography of the lower limb arteries from the aorta to the tibio-peroneal trunk in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 2006;31:53-8. [PMID: 16269254]
63. Diehm N, Kickuth R, Baumgartner I, Srivastav SK, Gretener S, Husmann MJ, et al. Magnetic resonance angiography in infrapopliteal arterial disease: prospective comparison of 1.5 and 3 Tesla magnetic resonance imaging. Invest Radiol. 2007;42:467-76. [PMID: 17507820]
64. Andreisek G, Pfammatter T, Goepfert K, Nanz D, Hervo P, Koppensteiner R, et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology. 2007;242:610-20. [PMID: 17179394]
65. Sutter R, Nanz D, Lutz AM, Pfammatter T, Seifert B, Struwe A, et al. Assessment of aortoiliac and renal arteries: MR angiography with parallel acquisition versus conventional MR angiography and digital subtraction angiography. Radiology. 2007;245:276-84. [PMID: 17717331]
66. Berg F, Bangard C, Bovenschulte H, Hellmich M, Nijenhuis M, Lackner K, et al. Feasibility of peripheral contrast-enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography. Invest Radiol. 2008;43:642-9. [PMID: 18708858]
67. Poschenrieder F, Hamer OW, Herold T, Schleicher T, Borisch I, Feuerbach S, et al. Diagnostic accuracy of intraarterial and i.v. MR angiography for the detection of stenoses of the infrainguinal arteries. AJR Am J Roentgenol. 2009;192:117-21. [PMID: 19098189]
68. Owen AR, Robertson IR, Annamalai G, Roditi GH, Edwards RD, Murray LS, et al. Critical lower-limb ischemia: the diagnostic performance of dual-phase injection MR angiography (including high-resolution distal imaging) compared with digital subtraction angiography. J Vasc Interv Radiol. 2009;20:165-72. [PMID: 19081736]
69. Ouwendijk R, de Vries M, Stijnen T, Pattynama PM, van Sambeek MR, Buth J, et al; Program for the Assessment of Radiological Technology. Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol. 2008;190:1349-57. [PMID: 18430854]
70. Menke J. Improving the image quality of contrast-enhanced MR angiography by automated image registration: A prospective study in peripheral arterial disease of the lower extremities. Eur J Radiol. 2009. [PMID: 19656648]
71. Menke J, Helms G, Larsen J. Viewing the effective k-space coverage of MR images: phantom experiments with fast Fourier transform. Magn Reson Imaging. 2010;28:87-94. [PMID: 19553053]
72. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ. 2003;326:41-4. [PMID: 12511463]
73. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al; Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138:W1-12. [PMID: 12513067]
74. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34. [PMID: 9310563]
75. de Vries M, Ouwendijk R, Flobbe K, Nelemans PJ, Kessels AG, Schurink GH, et al. Peripheral arterial disease: clinical and cost comparisons between duplex US and contrast-enhanced MR angiography - a multicenter randomized trial. Radiology. 2006;240:401-10. [PMID: 16864668]
76. Hay JW, Lawler E, Yucel K, Guo A, Balzer T, Gaziano JM, et al. Cost impact of diagnostic imaging for lower extremity peripheral vascular occlusive disease. Value Health. 2008. [PMID: 18657093]
77. Brenner DJ, Hall EJ. Computed tomography - an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-84. [PMID: 18046031]
78. Hunt CH, Hartman RP, Hesley GK. Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses. AJR Am J Roentgenol. 2009;193:1124-7. [PMID: 19770337]
79. Davenport MS, Cohan RH, Caoili EM, Ellis JH. Repeat contrast medium reactions in premedicated patients: frequency and severity. Radiology. 2009;253:372-9. [PMID: 19789241]
80. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-6. [PMID: 11979336]
81. Thomsen HS, Morcos SK. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT - a pooled analysis of two randomized trials. Eur Radiol. 2009;19:891-7. [PMID: 19002467]
82. Herts BR, Schneider E, Poggio ED, Obuchowski NA, Baker ME. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels. Radiology. 2008;248:106-13. [PMID: 18458249]
83. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284-94. [PMID: 18283206]
84. El-Hajjar M, Bashir I, Khan M, Min J, Torosoff M, DeLago A. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures. Am J Cardiol. 2008;102:353-6. [PMID: 18638601]
85. Collins R, Cranny G, Burch J, Aguiar-Ibáñez R, Craig D, Wright K, et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess. 2007;11:iii-iv, xi-xiii, 1-184. [PMID: 17462170]
86. Ouwendijk R, Kock MC, van Dijk LC, van Sambeek MR, Stijnen T, Hunink MG. Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors. Radiology. 2006;241:603-8. [PMID: 16966479]
87. U.S. Food and Drug Administration. Information for Healthcare Professionals: Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging (marketed as Magnevist, MultiHance, Omniscan, OptiMARK, ProHance). Silver Spring, MD: U.S. Food and Drug Administration; 2006. Accessed at www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm142884.htm on 15 July 2010.
88. Cowper SE, Rabach M, Girardi M. Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol. 2008;66:191-9. [PMID: 18325705]
89. Nainani N, Panesar M. Nephrogenic systemic fibrosis. Am J Nephrol. 2009;29:1-9. [PMID: 18663283]
90. Bhave G, Lewis JB, Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol. 2008;180:830-5; discussion 835. [PMID: 18635232]
91. Agarwal R, Brunelli SM, Williams K, Mitchell MD, Feldman HI, Umscheid CA. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009;24:856-63. [PMID: 18952698]
92. Altun E, Martin DR, Wertman R, Lugo-Somolinos A, Fuller ER 3rd, Semelka RC. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy - report from two U.S. universities. Radiology. 2009;253:689-96. [PMID: 19789233]
93. Brau AC, Beatty PJ, Skare S, Bammer R. Comparison of reconstruction accuracy and efficiency among autocalibrating data-driven parallel imaging methods. Magn Reson Med. 2008;59:382-95. [PMID: 18228603]
94. Okada T, Kanao S, Ninomiya A, Sato S, Kuhara S, Kamae T, et al. Whole-heart coronary magnetic resonance angiography with parallel imaging: comparison of acceleration in one-dimension vs. two-dimensions. Eur J Radiol. 2009;71:486-91. [PMID: 18640801]
95. Fenchel M, Doering J, Seeger A, Kramer U, Rittig K, Klumpp B, et al. Ultrafast whole-body MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study. Radiology. 2009;250:254-63. [PMID: 19001152]